Symptoms and Treatment of Parkinson’s Disease
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".
Deadline for manuscript submissions: 24 December 2024 | Viewed by 43
Special Issue Editors
Interests: Parkinson’s disease; movement disorders; cognitive assessment; genetic; frontotemporal dementia; alpha-synuclein; device-aided therapy
Interests: Parkinson’s disease; movement disorders; alpha-synuclein; bioinformatics; device-aided monitoring; device-aided therapy; biostatistics
Special Issue Information
Dear Colleagues,
Parkinson’s disease represents a major cause of neurodegeneration with an everincreasing worldwide prevalence. Recent research has focused on the individualized assessment of motor and non-motor symptoms. Device-aided remote monitoring has facilitated the in-depth evaluation of Parkinson’s disease symptomatology and distinct phenotypes. Moreover, the new developments witihn the field of genetics have increased our understanding on Parkinson’s disease pathogenesis. Underrepresented populations are in the spotlight of Parkinson’s disease research, so as to expand our knowledge of this complex disorder. On the other hand, new biomarkers including alpha-synuclein seeding assays and innovative imaging techniques have revolutionized Parkinson’s disease diagnosis.
Additionally, novel therapies, both symptomatic and disease modifying, are being developed and implemented. Device-aided treatments play a crucial role in the current therapeutics of this disorder. In this Special Issue, we welcome authors to submit papers concerning the clinical advancement of Parkinson’s disease in terms of both diagnosis and treatment.
Dr. Christos Koros
Dr. Nikolaos Papagiannakis
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Parkinson’s disease
- non-motor symptoms
- clinical progression
- cognitive assessment
- genetics
- remote monitoring
- biomarkers
- personalized medicine
- device-aided treatments
- disease-modifying therapies
